CCL5 as a Prognostic Marker for Survival and an Indicator for Immune Checkpoint Therapies in Small Cell Lung Cancer

Overview of attention for article published in Frontiers in Medicine, February 2022

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 955 followers.

CCL5 as a Prognostic Marker for Survival and an Indicator for Immune Checkpoint Therapies in Small Cell Lung Cancer https://t.co/qAagjcKhFP

New article: CCL5 as a Prognostic Marker for Survival and an Indicator for Immune Checkpoint Therapies in Small Cell Lung Cancer https://t.co/xCPZ1oMRC1 #lungcancer #oncology https://t.co/VF9CMvlRzI

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.